Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, September 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Efficiently Determine Growth Stimulants in Meat
Saturday, May 24, 2014
Determination of clenbuterol, ractopamine, and phenolethanolamine by using a dual rapid separation LC system.

Shimadzu Introduces C2P Automated Purification/Powderization System
Thursday, May 15, 2014
Crude2Pure for improved purity, efficiency and productivity.

Markes Announces Productivity-enhancing Improvements to its Range of TD Instruments
Thursday, May 15, 2014
Company has also announced improvements to its SafeLok TD sampling tubes.

Waters Introduces New Set of CORTECS Columns at HPLC 2014
Tuesday, May 13, 2014
New columns proven to maximize HPLC separation efficiency and throughput.

Agilent Technologies Introduces Next-Generation UHPLC Autosampler
Tuesday, May 13, 2014
1290 Infinity Multisampler sets new benchmark in capacity, speed and performance.

New Solid Phase Extraction Technology for Bioanalysis from Thermo Scientific
Tuesday, May 13, 2014
Designed to provide robust, reproducible extractions at low elution volumes.

EquipNet Celebrates 15 Successful Years in Business
Saturday, May 10, 2014
Company helps clients to generate a significant amount of previously unidentified funds from assets that have been sitting idle.

DataApex Releases Control Driver for Symbiosis™ Technology Components
Wednesday, May 07, 2014
Clarity chromatography software can newly control spark Symbiosis™ Technology Components.

Agilent Technologies Expands Availability of Chromosorb GC Packings
Tuesday, May 06, 2014
Full line of Chromosorb and century series now available.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 772
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv